David Jorden
Algemeen Directeur bij NUO THERAPEUTICS, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van David Jorden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NUO THERAPEUTICS, INC. | Directeur/Bestuurslid | 25-05-2015 | - |
Algemeen Directeur | 08-01-2016 | - | |
Financieel Directeur/CFO | 25-05-2015 | - | |
Bedrijfssecretaris | - | - | |
Voorzitter | 07-02-2012 | 25-05-2015 | |
Investor Relations Contact | 01-10-2008 | 07-02-2012 | |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Directeur/Bestuurslid | 01-06-2013 | - |
Algemeen Directeur | 01-06-2013 | - |
Loopbaan van David Jorden
Eerdere bekende functies van David Jorden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PLX PHARMA WINDDOWN CORP. | Financieel Directeur/CFO | 01-06-2015 | 01-07-2017 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Directeur/Bestuurslid | 12-08-2008 | 08-11-2013 |
Financieel Directeur/CFO | 14-08-2012 | 02-04-2013 | |
MORGAN STANLEY | Corporate Officer/Principal | 01-01-2003 | - |
Genometrix, Inc.
Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Genometrix, Inc. performs commercial physical and biological research. The private company is based in The Woodlands, TX. | Financieel Directeur/CFO | 01-03-2000 | 01-09-2002 |
Fayez Sarofim & Co.
Fayez Sarofim & Co. Investment ManagersFinance Fayez Sarofim & Co. (FSC) is a SEC-registered investment advisor headquartered in Houston, Texas. The firm was founded by Fayez Sarofim in 1958 and is a wholly-owned subsidiary of The Sarofim Group, Inc. FSC manages investment portfolios for a wide range of clients which includes pension plans, foundations, endowments and individuals. | Corporate Officer/Principal | - | - |
PLx Pharma, Inc. /Old/
PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX. | Directeur/Bestuurslid | - | - |
Financieel Directeur/CFO | - | - |
Opleiding van David Jorden
The University of Texas at Austin | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Director of Finance/CFO | 5 |
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 6 |
Finance | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MORGAN STANLEY | Finance |
NUO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
PLx Pharma, Inc. /Old/
PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX. | Health Technology |
Genometrix, Inc.
Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Genometrix, Inc. performs commercial physical and biological research. The private company is based in The Woodlands, TX. | Commercial Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Fayez Sarofim & Co.
Fayez Sarofim & Co. Investment ManagersFinance Fayez Sarofim & Co. (FSC) is a SEC-registered investment advisor headquartered in Houston, Texas. The firm was founded by Fayez Sarofim in 1958 and is a wholly-owned subsidiary of The Sarofim Group, Inc. FSC manages investment portfolios for a wide range of clients which includes pension plans, foundations, endowments and individuals. | Finance |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
PLx Pharma, Inc.
PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE. | Health Technology |
- Beurs
- Insiders
- David Jorden
- Ervaring